drugset / Trial / NCT00953459
Sunitinib Malate in Treating Patients With Small Cell Lung Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
RATIONALE: Sunitinib malate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. PURPOSE: This phase II trial is studying how well sunitinib malate works in treating patients with small cell lung cancer.
Timeline
- Start
- 2009-02
- Primary completion
- 2010-07
- Completion
- 2012-09
Outcome
Outcome not reported
Stopped (Enrollment): “poorly recruiting”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sunitinib | Small molecule | — | Oral |